These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


170 related items for PubMed ID: 26100992

  • 1. Spectrum of Histopathological Findings in Live Donor Liver Graft Biopsies.
    Tariq H, Nasir H.
    J Coll Physicians Surg Pak; 2015 Jun; 25(6):412-6. PubMed ID: 26100992
    [Abstract] [Full Text] [Related]

  • 2. Comparison of histopathology in acute allograft rejection and recurrent hepatitis C infection after liver transplantation.
    Petrovic LM, Villamil FG, Vierling JM, Makowka L, Geller SA.
    Liver Transpl Surg; 1997 Jul; 3(4):398-406. PubMed ID: 9346770
    [Abstract] [Full Text] [Related]

  • 3. Hepatitis C recurrence is not adversely affected by the use of donation after cardiac death liver allografts.
    Tao R, Ruppert K, Cruz RJ, Malik SM, Shaikh O, Ahmad J, DiMartini A, Humar A, Fontes PA, de Vera ME.
    Liver Transpl; 2010 Nov; 16(11):1288-95. PubMed ID: 21031544
    [Abstract] [Full Text] [Related]

  • 4. C4d in acute rejection after liver transplantation and its usefulness in differential diagnosis between acute liver rejection and hepatitis C recurrence.
    Gierej B, Kobryń K, Gierej P, Górnicka B.
    Ann Transplant; 2014 Aug 01; 19():373-81. PubMed ID: 25082343
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of chronic HCV infection in transplanted livers using a modified histological activity index.
    Ziarkiewicz-Wroblewska B, Wroblewski T, Ziolkowski J, Cieslak B, Oldakowska-Jedynak U, Mucha K, Foroncewicz B, Paczek L, Krawczyk M, Malejczyk J, Zimmermann A.
    Ann Transplant; 2011 Aug 01; 16(1):26-33. PubMed ID: 21436771
    [Abstract] [Full Text] [Related]

  • 6. Characterization of CD4, CD8, CD56 positive lymphocytes and C4d deposits to distinguish acute cellular rejection from recurrent hepatitis C in post-liver transplant biopsies.
    Jain A, Ryan C, Mohanka R, Orloff M, Abt P, Romano J, Bryan L, Batzold P, Mantry P, Bozorgzadeh A.
    Clin Transplant; 2006 Aug 01; 20(5):624-33. PubMed ID: 16968489
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. ELISA-based detection of C4d after liver transplantation--a helpful tool for differential diagnosis between acute rejection and HCV-recurrence?
    Schmeding M, Kienlein S, Röcken C, Neuhaus R, Neuhaus P, Heidenhain C, Neumann UP.
    Transpl Immunol; 2010 Aug 01; 23(4):156-60. PubMed ID: 20558292
    [Abstract] [Full Text] [Related]

  • 9. Histological and clinical outcome after liver transplantation for hepatitis C.
    Shuhart MC, Bronner MP, Gretch DR, Thomassen LV, Wartelle CF, Tateyama H, Emerson SS, Perkins JD, Carithers RL.
    Hepatology; 1997 Dec 01; 26(6):1646-52. PubMed ID: 9398011
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A prospective evaluation of fibrosis progression in patients with recurrent hepatitis C virus following liver transplantation.
    Yilmaz N, Shiffman ML, Stravitz RT, Sterling RK, Luketic VA, Sanyal AJ, Mills AS, Contos MJ, Coterell A, Maluf D, Posner MP, Fisher RA.
    Liver Transpl; 2007 Jul 01; 13(7):975-83. PubMed ID: 17600360
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Evolution of hepatitis C virus in liver allografts.
    Demetris AJ.
    Liver Transpl; 2009 Nov 01; 15 Suppl 2():S35-41. PubMed ID: 19876940
    [Abstract] [Full Text] [Related]

  • 15. Change in composition of inflammatory infiltrate in the course of hepatitis C reinfection and concomitant acute rejection after orthotopic liver transplantation.
    Ziarkiewicz-Wróblewska B, Wróblewski T, Ciszek M, Kalinowski P, Malejczyk J.
    Ann Transplant; 2014 Jan 24; 19():41-50. PubMed ID: 24457607
    [Abstract] [Full Text] [Related]

  • 16. Natural history of post-liver transplantation hepatitis C: A review of factors that may influence its course.
    Gallegos-Orozco JF, Yosephy A, Noble B, Aqel BA, Byrne TJ, Carey EJ, Douglas DD, Mulligan D, Moss A, de Petris G, Williams JW, Rakela J, Vargas HE.
    Liver Transpl; 2009 Dec 24; 15(12):1872-81. PubMed ID: 19938138
    [Abstract] [Full Text] [Related]

  • 17. Rapidly progressive recurrent hepatitis C virus infection starting 9 days after liver transplantation.
    Saraf N, Fiel MI, Deboccardo G, Emre S, Schiano TD.
    Liver Transpl; 2007 Jun 24; 13(6):913-7. PubMed ID: 17539015
    [Abstract] [Full Text] [Related]

  • 18. Immunohistochemical staining of liver grafts with a monoclonal antibody against HCV-Envelope 2 for recurrent hepatitis C after living donor liver transplantation.
    Sadamori H, Yagi T, Iwagaki H, Matsuda H, Shinoura S, Umeda Y, Ohara N, Yanai H, Ogino T, Tanaka N.
    J Gastroenterol Hepatol; 2009 Apr 24; 24(4):574-80. PubMed ID: 19368635
    [Abstract] [Full Text] [Related]

  • 19. Differential allograft gene expression in acute cellular rejection and recurrence of hepatitis C after liver transplantation.
    Sreekumar R, Rasmussen DL, Wiesner RH, Charlton MR.
    Liver Transpl; 2002 Sep 24; 8(9):814-21. PubMed ID: 12200784
    [Abstract] [Full Text] [Related]

  • 20. Clinical value and safety of liver biopsies in patients transplanted for hepatitis C virus-related end-stage liver disease.
    Brauner C, Lankisch TO, Fytili P, Jaroszewicz J, Lehner F, Barg-Hock H, Klempnauer J, Jaeckel E, Manns MP, Wedemeyer H, Negm AA.
    Transpl Infect Dis; 2014 Dec 24; 16(6):958-67. PubMed ID: 25393916
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.